Clinical Trial Update: Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib

View source ↗

Summary

This completed clinical trial assesses quality of life in non-transplant candidate multiple myeloma patients treated with early bortezomib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Multiple Myeloma | Status: COMPLETED